VL:VH domain rotations in engineered antibodies: Crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs

The crystal structures of two pairs of Fab fragments have been determined. The pairs comprise both a murine and an engineered human form, each derived from the antitumor antibodies A5B7 and CTM01. Although antigen specificity is maintained within the pairs, antigen affinity varies. A comparison of the hypervariable loops for each pair of antibodies shows their structure has been well maintained in grafting, supporting the canonical loop model. Detailed structural analysis of the binding sites and domain arrangements for these antibodies suggests the differences in antigen affinity observed are likely to be due to inherent flexibility of the hypervariable loops and movements at the VL:VH domain interface. The four structures provide the first opportunity to study in detail the effects of protein engineering on specific antibodies. Proteins 29:161–171, 1997. © 1997 Wiley‐Liss, Inc.

[1]  M. Holmes,et al.  Structural consequences of humanizing an antibody. , 1997, Journal of immunology.

[2]  R. Read.  Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[3]  R L Stanfield,et al.  Major antigen-induced domain rearrangements in an antibody. , 1993, Structure.

[4]  I. Wilson,et al.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition. , 1994, Science.

[5]  L. Hope-Stone,et al.  carcinoembryonic antigen: phase I/Il study with comparative biodistribution of intact and F(ab') antibodies , 2007 .

[6]  R. Wallace,et al.  Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. , 1993, Cancer research.

[7]  A T Brünger,et al.  Protein hydration observed by X-ray diffraction. Solvation properties of penicillopepsin and neuraminidase crystal structures. , 1994, Journal of molecular biology.

[8]  T. Bhat,et al.  Bound water molecules and conformational stabilization help mediate an antigen-antibody association. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[10]  A. Brunger.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[11]  M. Bodmer,et al.  Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment. , 1992, The Biochemical journal.

[12]  A. Lesk,et al.  Conformations of immunoglobulin hypervariable regions , 1989, Nature.

[13]  R. Owens,et al.  Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy. , 1995, British Journal of Cancer.

[14]  Timothy S. Baker,et al.  Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon , 1996, Nature.

[15]  César Milstein,et al.  Man-made antibodies , 1991, Nature.

[16]  A. Perkins,et al.  Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose. , 1996, Cancer research.

[17]  P. Carter,et al.  X‐ray structures of fragments from binding and nonbinding versions of a humanized anti‐CD18 antibody: Structural indications of the key role of VH residues 59 to 65 , 1994, Proteins.

[18]  G. N. Ramachandran,et al.  Conformation of polypeptides and proteins. , 1968, Advances in protein chemistry.

[19]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[20]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[21]  R. Owens,et al.  Humanization of an anti-mucin antibody for breast and ovarian cancer therapy. , 1994, Advances in experimental medicine and biology.